Filing Details
PRECISION BIOSCIENCES INC (NASDAQ:DTIL) filed a Form 8-K with the Securities and Exchange Commission on July 27, 2026, disclosing a material event.
8k filedNASDAQ:DTIL
PRECISION BIOSCIENCES INC (DTIL) Reports Material Event to SEC
Filing Details PRECISION BIOSCIENCES INC (NASDAQ:DTIL) filed a Form 8-K with the Securities and Exchange Commission on July 27, 2026, disclosing a material event. Market Context…
Market Context
PRECISION BIOSCIENCES INC's stock currently trades at $7.25 with a market capitalization of $65.0M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for PRECISION BIOSCIENCES INC's stock.
All SEC filings for PRECISION BIOSCIENCES INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View DTIL Stock Page
Frequently Asked Questions
Where can I read DTIL's SEC filings?
Browse all filings on our DTIL SEC filings page.
What types of SEC filings does PRECISION BIOSCIENCES INC file?
Public companies like PRECISION BIOSCIENCES INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.